ADIPOQ and type 2 diabetes mellitus: Concentration of adiponectin is markedly reduced in pathological conditions, such as type 2 diabetes mellitus (T2DM), obesity, and cardiovascular diseases (Achari and Jain, 2017; Rubina et al., 2021).